FDA-2026-P-2354

Requests that the FDA declare that the proposed drug product Levetiracetam Powder for Oral Solution, 250 mg/ sachet, 500 mg/sachet, 750 mg/sachet, and 1000 mg/sachet are suitable for consideration in an Abbreviated New Drug Application.